Delivery Order SPE2DR25D3012-SPE2DR26F4D1Z
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Levothyroxine 200 mcg tablets in quantities of 1,000 units, with a ceiling value of $13,837.62. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is scheduled for ultimate completion by September 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order for levothyroxine sodium to AmerisourceBergen Drug Corp on December 22, 2025, with a ceiling value of $2,962.37 and an ultimate completion date of January 21, 2026. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,485.56 to AmerisourceBergen Drug Corp for the supply of Levothyroxine 25 MCG tablets in quantities of 1,000 units. This is a firm fixed-price delivery order with no set-aside designation, issued competitively on September 25, 2025, with an ultimate completion date of September 26, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Levothyroxine 100 mcg/ml vials under a firm fixed-price contract valued at $2,015.19, with completion expected by October 20, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a pharmaceutical supply transaction within...
- The Defense Logistics Agency awarded a delivery order valued at $3,224.85 to AmerisourceBergen Drug Corp for the supply of Levothyroxine 75 MCG Capsule in quantities of 30 units. The contract, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizes firm fixed price pricing and does not include a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in the same...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,051.66 to AmerisourceBergen Drug Corp for the supply of Levothyroxine 137 mcg tablets (100-count units) with an ultimate completion date of July 22, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and was awarded on July 21, 2025. The contractor will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,414.38 to AmerisourceBergen Drug Corp for the supply of Levothyroxine Sodium, a synthetic thyroid hormone medication. The contract was competitively awarded on December 5, 2025, with an ultimate completion date of December 8, 2025, and is structured as a firm fixed price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Levothyroxine 200 micrograms, valued at $1,047.02 under a firm fixed-price contract type. The award was made on November 20, 2025, with an ultimate completion date of November 21, 2025. This is an unset-aside competitive award, and performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Levothyroxine is a synthetic thyroid hormone commonly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Levothyroxine 100 MCG vials under a firm fixed-price contract with a ceiling value of $4,231.47. This is a non-set-aside competitive award with an ultimate completion date of September 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Levothyroxine Sodium, a synthetic thyroid hormone used to treat hypothyroidism and other thyroid conditions. This firm fixed price delivery order has a ceiling value of $1,801.64 and is scheduled for completion by October 20, 2025. The contract was awarded without a set-aside designation through competitive procurement, with performance taking place at...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4D1ZDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Levothyroxine 150 MCG capsules (30-count units) with a ceiling value of $1,909.37. This firm fixed-price delivery order, with an ultimate completion date of December 11, 2025, is unclassified and carries no set-aside designation, indicating it was competitively awarded. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's comprehensive federal contract portfolio encompasses a wide range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains. This particular delivery order for hormone replacement therapy medications supports the DLA's Medical Supply Chain mission to ensure adequate pharmaceutical inventory for Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 12/9/25 |